ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Taxation/Internal Revenue Code TAX

Tax issues, including extension of the Research and Development Tax Credit and bilateral US-UK tax issues

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Treasury, Dept of

Trade (domestic/foreign) TRD

International trade issues, including free-trade agreements Import Safety

Contacted: Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Pharmacy PHA

FDA appropriations Support of sufficient funding for the Food & Drug Administration to conduct meaningful and effective review of direct-to-consumer advertising

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Treasury, Dept of; SENATE; U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

S.1145, The Patent Reform Act of 2007, Potential implications of pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries HR 5629, Pathway for Biosimilars Act Intellectual property provisions of free-trade agreements and otherwise as part of US trade policy

Contacted: Health & Human Services, Dept of (HHS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 5629 (110th), S. 1145 (110th)

Health Issues HCR

S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Bills named: S. 2029 (110th), S. 558 (110th), H.R. 1424 (110th)

Medicare/Medicaid MMM

Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 3118 (110th), H.R. 6331 (110th), S. 3101 (110th)

Consumer Issues/Safety/Products CSP

No specific legislation, but discussions regarding impact and safety issues surrounding the presence of pharmaceuticals in the environment Patient safety from the commercial importation of prescription medications Pharmaceutical Counterfeits Legislation HR 5839, The Safeguarding America's Pharmaceuticals Act

Contacted: SENATE; Treasury, Dept of; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5839 (110th)